Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Tolerability of Metacavir in Healthy Volunteers
NCT03180333Phase 1Completed
- Sponsor
- ApicHope Pharmaceutical Group
- Start
- Mar 2012
- Primary completion
- Aug 2012
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of metacavir in Chronic Hepatitis B (CHB) (5 arms), sponsored by ApicHope Pharmaceutical Group. Primary endpoint: Treatment-Emergent Adverse Events. Started Mar 2012; status: completed.
02
Drugs
metacavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03180333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180333.